Viewing Study NCT02508168


Ignite Creation Date: 2025-12-24 @ 5:45 PM
Ignite Modification Date: 2026-01-03 @ 9:30 AM
Study NCT ID: NCT02508168
Status: COMPLETED
Last Update Posted: 2016-10-05
First Post: 2015-07-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Bioavailability Study of SYR-322MET
Sponsor: Takeda
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module